INT169904

Context Info Confidence 0.65 First Reported 2001 Last Reported 2001 Negated 0 Speculated 0 Reported most in Body Documents 1 Total Number 3 Disease Relevance 0.22 Pain Relevance 0

Pain Term Frequency Confidence Heat cINOD 12 5.00 Potency 6 5.00

Disease Term Frequency Confidence Heat Cancer 27 71.72 Bladder Cancer 3 5.00 Myelodysplastic Syndromes 3 5.00 Hyperplasia 6 5.00 Retinoblastoma 3 5.00 Repression 12 5.00 Apoptosis 18 5.00 Breast Cancer 3 5.00 Thrombocytopenia 3 5.00 Acute Erythroblastic Leukemia 6 5.00

Sentences Mentioned In

Key:

Protein

Mutation

Event

Anatomy

Negation

Speculation

Pain term

Disease term

g/ml were p21/Cip (Pharmingen Inc, San Diego, CA, USA), pRb (IF8), p107 (SD9), p130 (C-20), E2F-1 (C-20), E2F-4(C-20) and PCNA (C-20) (Santa Cruz Biotechnology Inc, Santa Cruz, CA, USA).

Gene_expression (/) of C-20

1) Confidence 0.65 Published 2001 Journal Breast Cancer Res Section Body Doc Link PMC13923 Disease Relevance 0.07 Pain Relevance 0

g/ml were p21/Cip (Pharmingen Inc, San Diego, CA, USA), pRb (IF8), p107 (SD9), p130 (C-20), E2F-1 (C-20), E2F-4(C-20) and PCNA (C-20) (Santa Cruz Biotechnology Inc, Santa Cruz, CA, USA).

Gene_expression (/) of C-20

2) Confidence 0.65 Published 2001 Journal Breast Cancer Res Section Body Doc Link PMC13923 Disease Relevance 0.07 Pain Relevance 0

g/ml were p21/Cip (Pharmingen Inc, San Diego, CA, USA), pRb (IF8), p107 (SD9), p130 (C-20), E2F-1 (C-20), E2F-4(C-20) and PCNA (C-20) (Santa Cruz Biotechnology Inc, Santa Cruz, CA, USA).

Gene_expression (/) of C-20

3) Confidence 0.65 Published 2001 Journal Breast Cancer Res Section Body Doc Link PMC13923 Disease Relevance 0.07 Pain Relevance 0

General Comments

This test has worked.